[Ohio] Clinical Criteria updates
Summary
Anthem Ohio Medicaid/MyCare Ohio has revised six clinical criteria policies for medical drug benefits, effective January 1, 2027. These revisions affect asparagine-specific enzymes, bevacizumab, radioimmunotherapy agents, nivolumab, avelumab, and amivantamab products. Billing teams must review updated medical necessity requirements and obtain prior authorization according to separate notice guidance to avoid claim denials.
Get alerts when payers change rules like this one
We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.